Edwards A D
J Intraven Nurs. 1999 Sep-Oct;22(5):273-9.
Pain management is rapidly changing as the mysteries of how healthy and damaged nervous systems work to communicate pain to the brain become better understood. The role of subcutaneous or intravenous lidocaine in the management of neuropathic pain has been increasingly studied. Patients with a variety of pain have been shown to benefit from this therapy, including patients with cancer, postherpetic neuralgia, second degree burns, strokes, and diabetes. As research and experience grow, so too will the practitioner's ability to successfully use intravenous and subcutaneous lidocaine therapy for their patients with pain.
随着健康和受损神经系统如何将疼痛信号传递给大脑的奥秘被更好地理解，疼痛管理正在迅速变化。皮下或静脉注射利多卡因在神经性疼痛管理中的作用已得到越来越多的研究。各种疼痛患者已被证明可从这种治疗中受益，包括癌症患者、带状疱疹后神经痛患者、二度烧伤患者、中风患者和糖尿病患者。随着研究和经验的积累，从业者成功地为疼痛患者使用静脉和皮下利多卡因治疗的能力也将不断提高。
